Results 151 to 160 of about 4,732 (172)

Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users

Psychopharmacology, 2007
Kenzie Preston, Marilyn Huestis, Gérard Le Fur   +2 more
exaly  

Rimonabant: The first therapeutically relevant cannabinoid antagonist

Life Sciences, 2005
Giancarlo Colombo, Mauro A M Carai
exaly  

Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway

Acta Pharmacologica Sinica, 2010
Yao-Jen Liang, Chia-Ti Tsai
exaly  

Rimonabant Caution

JAMA, 2007
openaire   +1 more source

Sub-chronic administration of rimonabant causes loss of antidepressive activity and decreases doublecortin immunoreactivity in the mouse hippocampus

Neuroscience Letters, 2009
Jong Hoon Ryu, Seungjoo Lee
exaly  

Rimonabant/sibutramine

Reactions Weekly, 2008
openaire   +1 more source

Rimonabant

Drugs, 2012
Dean Robinson, Katherine Lyseng-Williamson, Robinson Dean M   +2 more
exaly  

Rimonabant

2016
openaire   +1 more source

An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity

Journal of Clinical Pharmacy and Therapeutics, 2011
exaly  

Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial

Schizophrenia Research, 2012
Deanna Kelly, James Waltz, Douglas L Boggs   +2 more
exaly